Lobular Carcinoma In Situ: Is It Cancer? - EmpowHER.com

Links shared publicly online about this topic.

  • 77
    total visits

Lobular Carcinoma In Situ: Is It Cancer? - EmpowHER.com

empowher.com

What is lobular carcinoma in situ? The name doesn't sound very reassuring. But lobular carcinoma in situ (LCIS) is not a cancer.

View full resource at empowher.com

Tags: Cancer, Breast Cancer, Women's Health

  • Share

Most Recently Shared on August 13, 2011 at 12:05 am By:

EmpowHER EmpowHER

LCIS is not a cancer, but may be a warning that you may be at high risk for breast cancer: http://ow.ly/5ZKQY

8 months ago...

Oncology News - Serum Autoantibody Signature of Ductal Carcinoma In Situ Progression to Invasive Breast Cancer |3992014

mdlinx.com — “Oncology Medical Article: Serum Autoantibody Signature of Ductal Carcinoma In Situ Progression to Invasive Breast CancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 6:26 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Serum Autoantibody Signature of Ductal Carcinoma In Situ Progression to Invasive Breast Cancer: Clinic... http://t.co/RZ7t4Okd #oncology

4 weeks ago...

RT after surgery could reduce chances of local DCIS recurrence by 50%

news-medical.net — “Radiotherapy treatment (RT) after surgery for ductal carcinoma in situ (DCIS) still has a major protective effect against recurrence more than 15 years later, according to the results of an international trial.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 7:30 am By:

BreastCancers News-Medical.Net Health News

Breast Cancer News: RT after surgery could reduce chances of local DCIS recurrence by 50%: Radiotherapy treatmen... http://t.co/4G4gOd9U

1 month ago...

Medical Staff Confuse Women With Ductal Carcinoma In Situ: Is It Breast Cancer, Or Not?

medicalnewstoday.com — “Women diagnosed with ductal carcinoma in situ (DCIS) need clear communication and tailored support to enable them to understand this complex breast condition, which has divided the medical professView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 7:05 am By:

BreastCancer_OW Breast Cancer OW OW Health

Medical Staff Confuse Women With Ductal Carcinoma In Situ: Is It Breast Cancer, Or Not?: Women diagnosed with du... http://t.co/SStVFHuW

1 month ago...

Margin threshold for women with ductal carcinoma in situ

eurekalert.org — “Negative surgical margins should be attained for ductal carcinoma in situ (DCIS) patients after breast-conserving surgery (BCS) regardless of radiotherapy, and surgeons should attempt to reach wide negative margins in their first attempt within cosmetic restraint according to a study published March 22 in the Journal of the National Cancer Institute.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 8:02 pm By:

EurekAlertAAAS EurekAlert! Health News

Via @JNCI_Now : Margin threshold for women with ductal carcinoma in situ. http://t.co/3bC0NPw2 #cancer

1 month ago...

Hormone receptor status influences benefit of tamoxifen in DCIS - The Doctor's Channel

thedoctorschannel.com — “NEW YORK (Reuters Health) – The reduced risk of developing invasive breast cancer with adjuvant tamoxifen therapy after lumpectomy and radiation for ductal carcinoma in situ (DCIS) is confined to estrogen receptor (ER)-positive disease, according to the results of a retrospective...View full resource at thedoctorschannel.com

  • View Related
  • Share

Most Recently Shared on March 9, 2012 at 11:22 pm By:

doctorschannel Dr Michael Banks - The Doctor's Channel Health Site

How does hormone receptor status influence the effects of tamoxifen? - From Reuters Health/TDC http://t.co/XkPkgYBA #oncology #health

1 month ago...

Four-Week Vaccination Regimen Knocks Out Early Breast Cancer Tumors

newswise.com — “Researchers at the Perelman School of Medicine at the University of Pennsylvania report that a short course of vaccination with an anti-HER2 dendritic cell vaccine made partly from the patient’s own cells triggers a complete tumor eradication in nearly 20 percent of women with ductal carcinoma in situ (DCIS), an early breast cancer.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on January 31, 2012 at 9:30 pm By:

Women with Cancer: Genomic testing can now guide DCIS treatment decisions

womenwcancer.blogspot.com — “Please join me as I develop an on-line community that supports, empowers and motivates women with cancerView full resource at womenwcancer.blogspot.com

  • View Related
  • Share

Most Recently Shared on December 7, 2011 at 3:03 pm By:

BrstCancerNews Breast Cancer News Health News

WomenWCancer: Genomic testing can now guide DCIS treatment decisions http://t.co/uCz4b9WX Full http://t.co/jRPApIQM

5 months ago...

Among women diagnosed with DCIS, risk of death from breast cancer was low, at least within the 10 years following diagnosis. This may reflect the effectiveness of treatment for DCIS, the "benign" nature of DCIS, or both. | GreenMedInfo | Article

greenmedinfo.com — “This article on GreenMedInfo.com concerns - Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program.View full resource at greenmedinfo.com

  • View Related
  • Share

Most Recently Shared on November 1, 2011 at 9:47 pm By:

As reported earlier... | Facebook

facebook.com — “Columbia University Department of Surgery wrote: As reported earlier this year, the drug... Join Facebook to connect with Columbia University Department of Surgery and others you may know.View full resource at facebook.com

  • View Related
  • Share

Most Recently Shared on October 22, 2011 at 11:00 am By:

ColumbiaSurgery Columbia Surgery Hospital

Is exemestane effective in preventing all forms of breast cancer? http://t.co/Kv8YOItU

6 months ago...

Health Reporter Chooses Double Breast Removal - ABC News

abcnews.go.com — “ABC News’ Carrie Gann reports: Linda Hurtado, a health reporter for WFTS in Tampa, Fla., had an emotional on-air discussion on Tuesday about her decision to have both of her breasts removed after she discovered she had a ductal carcinoma in situ, or DCIS, a growth that can lead to invasive breast cancer. Hurtado told viewers that she was always burdened by her family’s history of breast cancer. “I’ve lived my whole adult life in fear of getting breast cancer,” HurtaView full resource at abcnews.go.com

  • View Related
  • Share

Most Recently Shared on October 12, 2011 at 10:46 pm By:

SusanS_Health Susan Scroggins Health Advocate and Active Health Library

Reporter Chooses Double Breast Removal: ABC News’ Carrie Gann reports: Linda Hurtado, a health reporter for WFTS... http://t.co/W5XfYtgv

6 months ago...

How is LCIS typically diagnosed?

healthtap.com — “Patients with Lobular carcinoma in situ (LCIS) typically do not have any symptoms and the abnormality cannot usually be seen on mammograms. It is usually diagnosed when a breast biopsy is performed for other reasons, such as an unrelated breast lump. The examination of the tissue by a pathologist under a microscope shows the abnormal cells found in LCIS.View full resource at healthtap.com

  • View Related
  • Share

Most Recently Shared on September 7, 2011 at 9:41 pm By:

Oncology Article | Mastectomy

mdlinx.com — “Disparities in Reconstruction Rates after Mastectomy for Ductal Carcinoma in Situ (DCIS): Patterns of Care and Factors Associated with the Use of Breast Reconstruction for DCIS Compared with Invasive CancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 7, 2011 at 11:44 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Disparities in Reconstruction Rates after Mastectomy for Ductal Carcinoma in Situ (DCIS): Patterns of ... http://t.co/5bPsjlF #oncology

8 months ago...

Surgery Article | Mastectomy

mdlinx.com — “Disparities in Reconstruction Rates after Mastectomy for Ductal Carcinoma in Situ (DCIS): Patterns of Care and Factors Associated with the Use of Breast Reconstruction for DCIS Compared with Invasive CancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 6, 2011 at 12:04 pm By:

plsurgeon Dr Subhas Gupta Active Health Library, Doctor, Surgeon, Plastic Surgeon, and Physician

#plasticsurgery Disparities in Reconstruction Rates after Mastectomy for Ductal Carcinoma in Situ (DCIS): Patter... http://t.co/QOQDAiI

8 months ago...

How is invasive lobular carcinoma (ilc) usually diagnosed?

healthtap.com — “The only way to definitively diagnose any cancer is by obtaining a tissue sample via a biopsy. For breast cancer this can be done as a core needle biopsy (sometimes using mammogram and ultrasound guidance), a wire needle localization biopsy, or a surgical biopsy. The pathologist then examines the biopsy tissue under a microscope and determines whether there are cancer cells present.View full resource at healthtap.com

  • View Related
  • Share

Most Recently Shared on September 2, 2011 at 10:33 pm By:

zadehmd Michael A. Zadeh, M.D. Doctor, Surgeon, and Physician

#HealthTap: How is invasive lobular carcinoma (ilc) usually diagnosed? Answer http://t.co/A8DEMJA

8 months ago...

Oncology Article | ductal carcinoma

mdlinx.com — “Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 2, 2011 at 1:54 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ: Cancer http://t.co/lKeNBoM #oncology

8 months ago...

Advertisement